Ipamorelin 5mg

Your Trusted Source for Dragon Pharma Ipamorelin Peptide

Dragon Pharma Ipamorelin 5mg is a selective pentapeptide commonly used in biochemical and endocrine research to explore growth hormone secretagogue pathways and pituitary modulation.

Product Overview

Dragon Pharma Ipamorelin 5mg is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS). Developed for scientific and research purposes, it acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). This compound is widely studied to investigate the physiological regulation of growth hormone release, energy balance, and tissue signaling. As with all Dragon Pharma peptides, this product is lab-tested for purity and consistency, ensuring reliable experimental outcomes in peptide research.

Mechanism of Action

Ipamorelin functions by binding to the GHS-R1a receptor, stimulating endogenous growth hormone (GH) release through pituitary signaling without significantly affecting other hormonal axes such as cortisol or prolactin. This receptor-specific action makes Dragon Pharma Ipamorelin a valuable compound for studies exploring peptide selectivity, endocrine feedback loops, and hypothalamic-pituitary axis modulation. Research frequently examines its distinct profile compared to other GH secretagogues such as GHRP-2 and GHRP-6, providing insight into receptor affinity, desensitization patterns, and secretory pulsatility.

Key Ipamorelin Benefits & Applications

• Investigated for its selective stimulation of growth hormone release in vitro and in vivo models
• Useful in research exploring endocrine regulation and feedback suppression mechanisms
• Employed to compare receptor specificity across multiple GHS receptor ligands
• Studied for its role in cellular growth, protein synthesis, and recovery-related pathways
• Valuable for evaluating combined effects with other peptides like tesamorelin or GHRP-6

Storage

Reconstitution commonly involves bacteriostatic water to achieve desired study concentrations.

Form: Lyophilized powder for maximum stability.
Conditions:
Short-term: Refrigerate at 2–8°C.
Long-term: Store at -80°C for extended preservation.
Handling: Avoid freeze-thaw cycles; aliquot for experimental use. Protect from light, air, and moisture.
Solution Stability: Use sterile buffers (pH 5–6); store at 4°C for up to 30 days or freeze for longer periods.

For research purposes only. Not for human use or therapeutic applications.

Lab-Tested for Quality and Purity

Dragon Pharma Ipamorelin undergoes analytical verification including HPLC and mass spectrometry testing to confirm peptide integrity, purity, and sequence accuracy. Each batch is produced under strict research-grade conditions to ensure reproducibility across experimental applications.

Dosage, Administration and Who to Stack with Other Peptides

Experimental concentrations may vary depending on study design. Literature-based frameworks often model dosages in the range of 100–300 mcg per administration, performed once or multiple times daily in animal or in vitro studies. Administration is typically subcutaneous to observe GH-axis stimulation, though site and frequency can be adjusted for targeted investigations.

In laboratory models, Ipamorelin is frequently studied in combination with GHRH analogs such as Tesamorelin or CJC-1295 to evaluate synergistic effects on GH pulsatility. Comparative studies with GHRP-2 or GHRP-6 help clarify receptor selectivity and dose-response relationships across different peptide classes.

Post-Cycle Considerations

No post-cycle therapy (PCT) is required in research settings as Ipamorelin does not exhibit androgenic or suppressive properties on endogenous hormonal pathways. Experimental sequences can be discontinued or adjusted without rebound effects.

FAQ

What is Ipamorelin for men?

In laboratory contexts, Ipamorelin is studied for its effects on endocrine function, metabolic balance, and GH-axis stimulation. No claims are made regarding human use or therapeutic applications.

Is it safe to combine Tesamorelin with CJC/Ipamorelin together?

In research settings, scientists often study combined protocols involving Tesamorelin with CJC-1295 or Ipamorelin to evaluate synergistic GH secretion and receptor response. These combinations are strictly for experimental use.

Order Dragon Pharma CJC/Ipamorelin Peptide Blend.

Can you mix Sermorelin and Ipamorelin?

Yes, in research applications, Sermorelin and Ipamorelin are sometimes studied together to compare GHRH and GHS pathways. This combination allows for advanced analysis of peptide synergy in GH modulation models.

How much Ipamorelin should I take?

Experimental dosing typically ranges from 200–300 mcg per injection. These values are derived from literature-based research protocols and not intended as usage guidance.

Where to buy Ipamorelin?

Ipamorelin is available for research purchase through BuyDragonPharma.com, the official supplier of Dragon Pharma peptides.

External References

• Read more about Ipamorelin on PubChem
• Explore Ipamorelin studies on PubMed
• Overview of Ipamorelin on Wikipedia
• Tesamorelin and Ipamoreline